Gene · 7045
Papers3,774
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,774
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Fine Art of Writing a Message: RNA Metabolism in the Shaping and Remodeling of the Nervous System. | Front Mol Neurosci | 2021 | 34916907 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. | Cell | 2021 | 34914922 | PubTator, text mining | PubMed |
| Transcriptomics of single dose and repeated carbon black and ozone inhalation co-exposure highlight progressive pulmonary mitochondrial dysfunction. | Part Fibre Toxicol | 2021 | 34911549 | PubTator, text mining | PubMed |
| Hsa_circ_0008259 modulates miR-21-5p and PDCD4 expression to restrain osteosarcoma progression. | Aging (Albany NY) | 2021 | 34905503 | PubTator, text mining | PubMed |
| High Serpin Family A Member 10 Expression Confers Platinum Sensitivity and Is Associated With Survival Benefit in High-Grade Serous Ovarian Cancer: Based on Quantitative Proteomic Analysis. | Front Oncol | 2021 | 34888242 | PubTator, text mining | PubMed |
| Epiphycan Predicts Poor Outcomes and Promotes Metastasis in Ovarian Cancer. | Front Oncol | 2021 | 34888227 | PubTator, text mining | PubMed |
| Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets. | Nat Cell Biol | 2021 | 34887515 | PubTator, text mining | PubMed |
| Characterization of the Transient Deficiency of PKC Isozyme Levels in Immature Cord Blood T Cells and Its Connection to Anti-Allergic Cytokine Profiles of the Matured Cells. | Int J Mol Sci | 2021 | 34884454 | PubTator, text mining | PubMed |
| Identification of Prognostic Biomarkers Originating From the Tumor Stroma of Betel Quid-Associated Oral Cancer Tissues. | Front Oncol | 2021 | 34869001 | PubTator, text mining | PubMed |
| Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology. | Front Oncol | 2021 | 34868996 | PubTator, text mining | PubMed |
Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target? | Cells | 2021 | 34831458 | PubTator, text mining | PubMed |
| Hypoxic Incubation Conditions for Optimized Manufacture of Tenocyte-Based Active Pharmaceutical Ingredients of Homologous Standardized Transplant Products in Tendon Regenerative Medicine. | Cells | 2021 | 34831095 | PubTator, text mining | PubMed |
| Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer. | Cancers (Basel) | 2021 | 34830879 | PubTator, text mining | PubMed |
| Spectrum of Genetic Diseases in Tunisia: Current Situation and Main Milestones Achieved. | Genes (Basel) | 2021 | 34828426 | PubTator, text mining | PubMed |
| Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer. | Front Cell Dev Biol | 2021 | 34805157 | PubTator, text mining | PubMed |
| Generation of Skin Organoids: Potential Opportunities and Challenges. | Front Cell Dev Biol | 2021 | 34805138 | PubTator, text mining | PubMed |
| Interrelation Between Fibroblasts and T Cells in Fibrosing Interstitial Lung Diseases. | Front Immunol | 2021 | 34804029 | PubTator, text mining | PubMed |
| Meta-Analysis of Esophageal Cancer Transcriptomes Using Independent Component Analysis. | Front Genet | 2021 | 34795689 | PubTator, text mining | PubMed |
| Current knowledge on the multiform reconstitution of intestinal stem cell niche. | World J Stem Cells | 2021 | 34786158 | PubTator, text mining | PubMed |
| Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma. | J Immunother Cancer | 2021 | 34782430 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7045/papers?page=56